(Press-News.org) WHAT: A large study found that greater exposure to long-term air pollution was linked with increased risks for blood clots that can occur in deep veins, which, if untreated, can block blood flow and cause serious complications, even death.
These findings came from a longitudinal study funded by the National Institutes of Health (NIH) that included 6,651 U.S. adults who were followed for an average of 17 years between 2000 and 2018. Participants lived in or near one of six major metropolitan areas: New York, Baltimore, Chicago, Los Angeles, Minneapolis, and Winston-Salem, North Carolina.
Throughout the study, 248 adults, 3.7% of the study sample, developed blood clots in deep veins that required hospital care. The likelihood of this outcome was linked to anywhere from a 39% to a more than two-fold increased risk based on long-term exposure to three different types of air pollutants.
Blood clots in deep veins, collectively known as venous thromboembolism (VTE), include deep vein thrombosis, which occurs when a blood clot forms in a deep vein of the legs, arms, or an internal organ, and pulmonary embolism, which occurs when a blood clot breaks off from a deep vein and travels to the lungs.
Exposure to air pollution, which can set the stage for inflammation and contribute to blood clotting, has long been associated with cardiovascular and respiratory diseases. While previous research has also suggested a link to VTE, this is the largest, most comprehensive U.S. study to report that association with three different types of air pollutants.
This included exposure to tiny air pollution particles equal to or less than 2.5 micrometers, which can be inhaled from a variety of sources, including smoke from coal-burning power plants, forest fires, and motor vehicle exhaust. Participants with greater overall exposure to this type of air pollution had a 39% increased associated risk for VTE compared to people exposed to lower levels. People with increased exposure to oxides of nitrogen and nitrogen dioxide, pollutants most often found from vehicle exhaust, had a respective 121% to 174% increased risk.
To reach these findings, the researchers analyzed the relationship between patients hospitalized for VTE and levels of air pollution collected through extensive biweekly community-level monitoring — including samples taken from the homes of participants. They then compared those with the highest exposure levels — the top 75% — to those with the lowest exposure — the bottom 25%. They also conducted multiple analyses to control for variables associated with VTE, such as age, exposure to tobacco, and underlying respiratory and other health conditions.
VTE affects up to 900,000 Americans each year. Many cases occur after surgery, but other factors, including age, long periods of inactivity, heart disease, pregnancy, and genetics, can increase risks.
The research, which is part of the Multi-Ethnic Study of Atherosclerosis (MESA), was funded by contracts and grants from NIH’s National Heart, Lung, and Blood Institute and National Center for Advancing Translational Sciences, and the Environmental Protection Agency.
WHO: Courtney Thornburg, M.D., a chief medical research officer at NHLBI, and the researchers are available to discuss these study findings.
Study: Lutsey P, Misialek J, Young M, et al. Air pollution is associated with increased risk of venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis. Blood. 2024; doi: https://doi.org/10.1182/blood.2024026399.
###
About the National Heart, Lung, and Blood Institute (NHLBI): NHLBI is the global leader in conducting and supporting research in heart, lung, and blood diseases and sleep disorders that advances scientific knowledge, improves public health, and saves lives. For more information, visit https://www.nhlbi.nih.gov/.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/.
NIH...Turning Discovery Into Health
END
Long-term exposure to air pollution linked to blood clots in veins that bring blood to the heart
An observational study of more than 6,500 adults is one of the most detailed in the U.S.
2024-12-12
ELSE PRESS RELEASES FROM THIS DATE:
National Academy of Inventors partners with PMU to recognize three exceptional innovators
2024-12-12
The National Academy of Inventors (NAI) is proud to announce the recipients of the inaugural Prince Mohammad bin Fahd University (PMU)-National Academy of Inventors International Patent Award. This year’s recipients will be honored at a special ceremony on December 12th, 2024 at PMU’s campus in Al-Khobar, Kingdom of Saudi Arabia.
The PMU-NAI International Patent Award was created to recognize and honor distinguished scientists, research institutions, research centers, and universities across the globe for their outstanding patents and inventions that create positive societal ...
Deep learning model accurately diagnoses COPD
2024-12-12
OAK BROOK, Ill. – Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).
COPD is a group of progressive lung diseases that impair a person’s ability to breathe. Symptoms typically involve shortness of breath and fatigue. There currently is no cure for COPD, and it is the third leading cause of death worldwide, according to the World Health Organization.
A ...
Alliance Foundation Trials phase III PATINA study shows promise for patients with HR+, HER2+ metastatic breast cancer
2024-12-12
Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE®) to current standard-of-care first-line maintenance therapy (following induction chemotherapy) resulted in statistically significant and clinically meaningful improvement in progression-free survival (PFS) by investigator assessment in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) metastatic ...
COMET trial finds quality of life similar among patients with low- risk DCIS whether they received active monitoring or surgery
2024-12-12
SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
The results of this study were simultaneously published in JAMA Oncology.
“Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who ...
Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation
2024-12-12
SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the same breast, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“Good-risk” DCIS was defined as grade 1 or 2, 2.5 cm or smaller, and having clear surgical margins of 3 mm or greater.
Current guidelines from the National Comprehensive Cancer Network (NCCN) advise that patients who undergo breast-conserving surgery after a diagnosis ...
COMET trial finds active monitoring is a viable option for some patients with low-risk DCIS
2024-12-12
SAN ANTONIO – Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast cancer recurrence rates as those who underwent guideline-concordant treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
The results of this study were simultaneously published in JAMA.
“Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who develop cancer.
A steady increase ...
Most patients with intermediate-risk breast cancer may safely avoid chest wall irradiation after mastectomy
2024-12-12
SAN ANTONIO – Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“While post-mastectomy CWI is the standard of care for most patients with early-stage breast cancer who have four or more positive axillary lymph nodes, its role in patients with fewer positive lymph nodes or node-negative disease remains controversial,” ...
Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ
2024-12-12
About The Study: Women with low-risk ductal carcinoma in situ randomized to active monitoring did not have a higher rate of invasive cancer in the same breast at 2 years compared with those randomized to guideline-concordant care.
Corresponding Author: To contact the corresponding author, E. Shelley Hwang, MD, MPH, email shelley.hwang@duke.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.26698)
Editor’s Note: Please ...
Patient-reported outcomes for low-risk ductal carcinoma in situ
2024-12-12
About The Study: In this prespecified secondary analysis of the Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) prospective randomized trial, the overall lived experience of women randomized to undergo active monitoring for low-risk ductal carcinoma in situ was similar to that of women randomized to guideline-concordant care during the 2 years following diagnosis.
Corresponding Author: To contact the corresponding author, Ann H. Partridge, MD, MPH, email ann_partridge@dfci.harvard.edu.
To access the embargoed study: Visit our For The Media website ...
Women born prematurely are at greater risk of committing suicide
2024-12-12
Not only are they the smallest among us, premature children also face health and life challenges that make them the most vulnerable. Generally speaking, they have a slightly higher risk of mortality due to illness. It is now apparent that they also have a higher risk of unexpected death from so-called external causes: road traffic accidents, substance abuse and suicide.
This has been revealed in a major Nordic study led by Professor Kari Risnes from the Faculty of Medicine and Health Sciences at the Norwegian University of Science and Technology (NTNU). The researchers have analyzed birth data and causes of death for nearly 37,000 individuals aged between 15 ...
LAST 30 PRESS RELEASES:
New grant to UMD School of Public Health will uncover “ghost networks” in Medicare plans
Researchers describe a potential target to address a severe heart disease in diabetic patients
U-M study of COVID-19 deaths challenges claims, understanding of pandemic-era suicides
How the dirt under our feet could affect human health
Screen time is a poor predictor of suicide risk, Rutgers researchers find
Dual-unloading mode revolutionizes rice harvesting and transportation
Researchers uncover strong light-matter interactions in quantum spin liquids
More dense, populated neighborhoods inspire people to walk more
Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion
New analytical approach revolutionizes reliability evaluation of power systems with renewable energy
Artificial intelligence improves mammography-based risk prediction
Brain tumors hijack circadian clock to grow
Pfizer-BioNTech vaccine for COVID-19 among children ages 5-17
Trends in school mental health and substance use education
Genes that determine tooth shape identified
With a little help from their friends: Poll shows role of close friendships in older adults’ health
Too much screen time can reduce sleep quality in preschool-age children, making behavioral problems worse
Study reveals role of allele dosage in improving sweetpotato traits
Dan M. Frangopol and Sunyong Kim co-author third book on structural performance
Ferroptosis and intrinsic drug-induced liver injury by acetaminophen and other drugs: a critical evaluation and historical perspective
Reiki therapy demonstrates significant symptom relief for cancer patients receiving infusion treatments
Long-term exposure to air pollution linked to blood clots in veins that bring blood to the heart
National Academy of Inventors partners with PMU to recognize three exceptional innovators
Deep learning model accurately diagnoses COPD
Alliance Foundation Trials phase III PATINA study shows promise for patients with HR+, HER2+ metastatic breast cancer
COMET trial finds quality of life similar among patients with low- risk DCIS whether they received active monitoring or surgery
Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation
COMET trial finds active monitoring is a viable option for some patients with low-risk DCIS
Most patients with intermediate-risk breast cancer may safely avoid chest wall irradiation after mastectomy
Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ
[Press-News.org] Long-term exposure to air pollution linked to blood clots in veins that bring blood to the heartAn observational study of more than 6,500 adults is one of the most detailed in the U.S.